Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Spring-summer net community production, new production, particle export and related water column biogeochemical processes in the marginal sea ice zone of the Western Antarctic Peninsula 2012-2014.

Ducklow HW, Stukel MR, Eveleth R, Doney SC, Jickells T, Schofield O, Baker AR, Brindle J, Chance R, Cassar N.

Philos Trans A Math Phys Eng Sci. 2018 Jun 28;376(2122). pii: 20170177. doi: 10.1098/rsta.2017.0177.

PMID:
29760119
2.

Categorisation of Colour Terms Using New Validation Tools: A Case Study and Implications.

Arbab S, Brindle JA, Matusiak BS, Klöckner CA.

Iperception. 2018 Mar 13;9(2):2041669518760043. doi: 10.1177/2041669518760043. eCollection 2018 Mar-Apr.

3.

Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial.

Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):e43-e49. doi: 10.1016/j.prro.2016.06.010. Epub 2016 Jun 24.

PMID:
27637137
4.

Preseason Aerobic Capacity Is an Independent Predictor of In-Season Injury in Collegiate Soccer Players.

Watson A, Brindle J, Brickson S, Allee T, Sanfilippo J.

Clin J Sport Med. 2017 May;27(3):302-307. doi: 10.1097/JSM.0000000000000331.

PMID:
27347859
5.

Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.

Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DWN, Pistenmaa D, Lotan Y, Timmerman R.

Eur J Cancer. 2016 May;59:142-151. doi: 10.1016/j.ejca.2016.02.014. Epub 2016 Mar 29.

PMID:
27035363
6.

The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellåker C, Vesely C, Ponting CP, McLaughlin PJ, Jantsch MF, Dorin J, Adams IR, Scadden AD, Ohman M, Keegan LP, O'Connell MA.

Cell Rep. 2014 Nov 20;9(4):1482-94. doi: 10.1016/j.celrep.2014.10.041. Epub 2014 Nov 13.

7.

Investigation of Nonuniform Dose Voxel Geometry in Monte Carlo Calculations.

Yuan J, Chen Q, Brindle J, Zheng Y, Lo S, Sohn J, Wessels B.

Technol Cancer Res Treat. 2015 Aug;14(4):419-27. doi: 10.1177/1533034614547459. Epub 2014 Sep 14.

PMID:
25223321
8.

Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.

Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):509-17. doi: 10.1016/j.ijrobp.2014.03.012.

PMID:
24929162
9.

Establishing a process of irradiating small animal brain using a CyberKnife and a microCT scanner.

Kim H, Fabien J, Zheng Y, Yuan J, Brindle J, Sloan A, Yao M, Lo S, Wessels B, Machtay M, Welford S, Sohn JW.

Med Phys. 2014 Feb;41(2):021715. doi: 10.1118/1.4861713.

PMID:
24506606
10.

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies.

Kunos CA, Brindle J, Waggoner S, Zanotti K, Resnick K, Fusco N, Adams R, Debernardo R.

Front Oncol. 2012 Dec 5;2:181. doi: 10.3389/fonc.2012.00181. eCollection 2012.

11.

Stereotactic radiosurgery for gynecologic cancer.

Kunos C, Brindle JM, Debernardo R.

J Vis Exp. 2012 Apr 17;(62). pii: 3793. doi: 10.3791/3793.

12.

Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies.

Kunos CA, Debernardo R, Radivoyevitch T, Fabien J, Dobbins DC, Zhang Y, Brindle J.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e35-41. doi: 10.1016/j.ijrobp.2012.02.027. Epub 2012 Apr 28.

PMID:
22543208
13.

18FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies.

Kunos CA, Debernardo R, Fabien J, Dobbins DC, Zhang Y, Brindle J, Faulhaber PF.

J Nucl Med Radiat Ther. 2011 Dec 12;Suppl 4(1). pii: 3117.

14.

Stereotactic body radiation therapy for nonresectable tumors of the pancreas.

Goyal K, Einstein D, Ibarra RA, Yao M, Kunos C, Ellis R, Brindle J, Singh D, Hardacre J, Zhang Y, Fabians J, Funkhouser G, Machtay M, Sanabria JR.

J Surg Res. 2012 May 15;174(2):319-25. doi: 10.1016/j.jss.2011.07.044. Epub 2011 Sep 5.

15.

Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects.

Marcucci R, Brindle J, Paro S, Casadio A, Hempel S, Morrice N, Bisso A, Keegan LP, Del Sal G, O'Connell MA.

EMBO J. 2011 Aug 16;30(20):4211-22. doi: 10.1038/emboj.2011.303.

16.

Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects.

Keegan LP, McGurk L, Palavicini JP, Brindle J, Paro S, Li X, Rosenthal JJ, O'Connell MA.

Nucleic Acids Res. 2011 Sep 1;39(16):7249-62. doi: 10.1093/nar/gkr423. Epub 2011 May 27.

17.

Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.

Boike TP, Lotan Y, Cho LC, Brindle J, DeRose P, Xie XJ, Yan J, Foster R, Pistenmaa D, Perkins A, Cooley S, Timmerman R.

J Clin Oncol. 2011 May 20;29(15):2020-6. doi: 10.1200/JCO.2010.31.4377. Epub 2011 Apr 4.

18.

Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies.

Kunos C, Chen W, DeBernardo R, Waggoner S, Brindle J, Zhang Y, Williams J, Einstein D.

Technol Cancer Res Treat. 2009 Oct;8(5):393-400.

PMID:
19754216
19.

Editing independent effects of ADARs on the miRNA/siRNA pathways.

Heale BS, Keegan LP, McGurk L, Michlewski G, Brindle J, Stanton CM, Caceres JF, O'Connell MA.

EMBO J. 2009 Oct 21;28(20):3145-56. doi: 10.1038/emboj.2009.244. Epub 2009 Aug 27.

20.

Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy.

Kunos C, von Gruenigen V, Waggoner S, Brindle J, Zhang Y, Myers B, Funkhouser G, Wessels B, Einstein D.

Technol Cancer Res Treat. 2008 Oct;7(5):375-80.

PMID:
18783287
21.

Method for estimating skeletal spongiosa volume and active marrow mass in the adult male and adult female.

Pichardo JC, Trindade AA, Brindle JM, Bolch WE.

J Nucl Med. 2007 Nov;48(11):1880-8. Epub 2007 Oct 17.

22.

CT volumetry of the skeletal tissues.

Brindle JM, Trindade AA, Pichardo JC, Myers SL, Shah AP, Bolch WE.

Med Phys. 2006 Oct;33(10):3796-803.

PMID:
17089844
23.

Linear regression model for predicting patient-specific total skeletal spongiosa volume for use in molecular radiotherapy dosimetry.

Brindle JM, Trindade AA, Shah AP, Jokisch DW, Patton PW, Pichardo JC, Bolch WE.

J Nucl Med. 2006 Nov;47(11):1875-83.

24.
25.

Image segmentation of trabecular spongiosa by visual inspection of the gradient magnitude.

Rajon DA, Pichardo JC, Brindle JM, Kielar KN, Jokisch DW, Patton PW, Bolch WE.

Phys Med Biol. 2006 Sep 21;51(18):4447-67. Epub 2006 Aug 22.

PMID:
16953037
26.

Tuning of RNA editing by ADAR is required in Drosophila.

Keegan LP, Brindle J, Gallo A, Leroy A, Reenan RA, O'Connell MA.

EMBO J. 2005 Jun 15;24(12):2183-93. Epub 2005 May 26.

27.

Meeting the challenge of Alzheimer's care.

Brindle JR.

RN. 2005 Jan;68(1):29-30, 32-4; quiz 35. Review. No abstract available.

PMID:
15742746
29.

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.

Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR; North Central Cancer Treatment Group.

J Clin Oncol. 2003 Sep 1;21(17):3201-6. Epub 2003 Jul 21.

PMID:
12874270
30.

A hyperboliod representation of the bone-marrow interface within 3D NMR images of trabecular bone: applications to skeletal dosimetry.

Rajon DA, Shah AP, Watchman CJ, Brindle JM, Bolch WE.

Phys Med Biol. 2003 Jun 21;48(12):1721-40.

PMID:
12870579
31.

Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension.

Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E.

Analyst. 2003 Jan;128(1):32-6.

PMID:
12572799
32.

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.

Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ.

Nat Med. 2002 Dec;8(12):1439-44. Epub 2002 Nov 25. Erratum in: Nat Med. 2003 Apr;9(4):477.

PMID:
12447357
33.

Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids.

Beckwith-Hall BM, Brindle JT, Barton RH, Coen M, Holmes E, Nicholson JK, Antti H.

Analyst. 2002 Oct;127(10):1283-8.

PMID:
12430596
34.

Micro-processing events in mRNAs identified by DHPLC analysis.

Gallo A, Thomson E, Brindle J, O'Connell MA, Keegan LP.

Nucleic Acids Res. 2002 Sep 15;30(18):3945-53.

35.

The properties of a tRNA-specific adenosine deaminase from Drosophila melanogaster support an evolutionary link between pre-mRNA editing and tRNA modification.

Keegan LP, Gerber AP, Brindle J, Leemans R, Gallo A, Keller W, O'Connell MA.

Mol Cell Biol. 2000 Feb;20(3):825-33.

36.

Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study.

Schomberg PJ, Shanahan TG, Ingle JN, Donohue JH, Kuske RR, Sternfeld WC, Wold L, Cha SS, Petersen IA, Brindle JS, Halyard MY, Bollinger JW, Hawkins R, Pisansky TM.

Radiology. 1997 Feb;202(2):565-9.

PMID:
9015091
37.

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B.

J Clin Oncol. 1997 Jan;15(1):277-84. Erratum in: J Clin Oncol 1997 Feb;15(2):866.

PMID:
8996153
38.
40.

Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes.

Baker HW, Brindle J, Irvine DS, Aitken RJ.

Fertil Steril. 1996 Feb;65(2):411-9.

PMID:
8566272
41.

Analysis of sperm movement in relation to the oxidative stress created by leukocytes in washed sperm preparations and seminal plasma.

Aitken RJ, Buckingham DW, Brindle J, Gomez E, Baker HW, Irvine DS.

Hum Reprod. 1995 Aug;10(8):2061-71.

PMID:
8567843
42.

Recombinant human zona pellucida protein ZP3 produced by chinese hamster ovary cells induces the human sperm acrosome reaction and promotes sperm-egg fusion.

van Duin M, Polman JE, De Breet IT, van Ginneken K, Bunschoten H, Grootenhuis A, Brindle J, Aitken RJ.

Biol Reprod. 1994 Oct;51(4):607-17.

PMID:
7819440
44.

Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma.

Brindle JS, Shaw EG, Su JQ, Mailliard JA, Frank AR, Laurie JA, McLean M, Tackett DM, Owens DT.

Cancer. 1993 Jul 15;72(2):405-9.

PMID:
8391378
45.

Locally recurrent non-small-cell lung cancer after complete surgical resection.

Shaw EG, Brindle JS, Creagan ET, Foote RL, Trastek VF, Buskirk SJ.

Mayo Clin Proc. 1992 Dec;67(12):1129-33.

PMID:
1335100
46.

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B.

N Engl J Med. 1992 Jun 11;326(24):1593-8.

47.

Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx.

Wiernik G, Alcock CJ, Bates TD, Brindle JM, Fowler JF, Gajek WR, Goodman S, Haybittle JL, Henk JM, Hopewell JW, et al.

Br J Radiol. 1991 Mar;64(759):232-41.

PMID:
2021797
48.

Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx.

Wiernik G, Bates TD, Bleehen NM, Brindle JM, Bullimore J, Fowler JF, Haybittle JL, Howard N, Laing AH, Lindup R, et al.

Br J Radiol. 1990 Mar;63(747):169-80.

PMID:
2185865
49.

Pelvic lymphadenectomy and transperineal interstitial implantation of IR 192 combined with external beam radiotherapy for bulky stage C prostatic carcinoma.

Brindle JS, Martinez A, Schray M, Edmundson G, Benson RC, Zincke H, Diokno A, Gonzalez J.

Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):1063-6.

PMID:
2808040
50.

First interim progress report on the second British Institute of Radiology Fractionation Study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx.

Wiernik G, Alcock CJ, Bates TD, Berry RJ, Brindle JM, Dalby JE, Fowler JF, Gajek WR, Goodman S, Haybittle JL, et al.

Br J Radiol. 1989 May;62(737):450-6.

PMID:
2653552

Supplemental Content

Loading ...
Support Center